Insider Shareholders with Direct Ownership of Pieris Pharmaceuticals, Inc. (PIRS)
This section provides a comprehensive overview of the insiders with direct ownership of Pieris Pharmaceuticals, Inc. (PIRS). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
PIERIS PHARMACEUTICALS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
George M Jenkins
Director |
4,000 | 0 | 180,671 $2.46 Million | 1 |
Dec 18, 2024
Added 2.17%
|
| 438,929 | 5,050,000 | 38,961 $529,869 | 3 |
Dec 13, 2024
Added 43.21%
|
|
|
Christopher P Kiritsy
Director |
10,000 | 0 | 20,000 $272,000 | 1 |
May 25, 2023
Added 33.33%
|
|
Tim Demuth
Chief Medical Officer |
6,000 | 0 | 6,000 $81,600 | 1 |
May 13, 2022
Added 50.0%
|
|
Shane Olwill
Chief Development Officer |
38,400 | 38,400 | 4,638 $63,076 | 2 |
Aug 30, 2021
Reduced 86.29%
|
|
James A Geraghty
Director |
1 | 1 | 0 $0 | 2 |
Dec 12, 2024
Reduced 100.0%
|